The Ontario Genomics Institute’s Pre-commercialization Business Development Fund (PBDF) is now open for another round of investment. The PBDF is an investment fund that enables the commercialization of ‘omics/life sciences research and technology development. Specifically, it aims to provide early-stage funding as companies (on their own or with academic collaborators) move towards commercial applications, and speed up the transfer of products from lab to marketplace. Applicants are welcome to put forward proposals in the proof of principal (validation) phase. The fund will look for a balance of the best science with the best opportunity and will consider opportunities where life science is or has been a key enabling component.

The general guidelines for investment and the application template can be found on the OGI website, PBDF’s page

Applications are due to OGI on September 29, 2014.

Contact the Business Development Team for further information. In addition, please feel free to distribute to colleagues who may be interested in this funding opportunity.